Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy
- 1 March 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (5), 2065-2071
- https://doi.org/10.1158/0008-5472.can-08-1735
Abstract
Aberrant epigenetic changes in DNA methylation and histone acetylation are hallmarks of most cancers, whereas histone methylation was previously considered to be irreversible and less versatile. Recently, several histone demethylases were identified catalyzing the removal of methyl groups from histone H3 lysine residues and thereby influencing gene expression. Neuroblastomas continue to remain a clinical challenge despite advances in multimodal therapy. Here, we address the functional significance of the chromatin-modifying enzyme lysine-specific demethylase 1 (LSD1) in neuroblastoma. LSD1 expression correlated with adverse outcome and was inversely correlated with differentiation in neuroblastic tumors. Differentiation of neuroblastoma cells resulted in down-regulation of LSD1. Small interfering RNA–mediated knockdown of LSD1 decreased cellular growth, induced expression of differentiation-associated genes, and increased target gene–specific H3K4 methylation. Moreover, LSD1 inhibition using monoamine oxidase inhibitors resulted in an increase of global H3K4 methylation and growth inhibition of neuroblastoma cells in vitro. Finally, targeting LSD1 reduced neuroblastoma xenograft growth in vivo. Here, we provide the first evidence that a histone demethylase, LSD1, is involved in maintaining the undifferentiated, malignant phenotype of neuroblastoma cells. We show that inhibition of LSD1 reprograms the transcriptome of neuroblastoma cells and inhibits neuroblastoma xenograft growth. Our results suggest that targeting histone demethylases may provide a novel option for cancer therapy. [Cancer Res 2009;69(5):2065–71]Keywords
Other Versions
This publication has 31 references indexed in Scilit:
- Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplificationBritish Journal of Cancer, 2007
- Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genesProceedings of the National Academy of Sciences of the United States of America, 2007
- Opposing LSD1 complexes function in developmental gene activation and repression programmesNature, 2007
- Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma OutcomeClinical Cancer Research, 2007
- Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expressionNature, 2007
- Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive MedicationsCell Chemical Biology, 2006
- An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylationNature, 2005
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcriptionNature, 2005
- Specific Features of Neuronal Size and Shape Are Regulated by Tropomyosin IsoformsMolecular Biology of the Cell, 2005
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004